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The increasing number of tuberculosis (TB) infections with multi-
drug resistant (MDR) Mycobacterium tuberculosis strains causes a
severe worldwide health problem, necessitating the development of
new antibiotics. A novel drug, the diarylquinoline TMC207, was found
to be highly effective in the treatment of MDR-TB. It was reported that
the drug targets the rotor ring of the energy converting enzyme F1Fo-
ATP synthase, which is essential for the survival of mycobacteria.
However, structural and biochemical information about the precise
binding site of TMC207 and its mechanism of action are not known
at the level of the isolated ATP synthase or its rotor ring complex.
We performed ATP synthesis experiments on a mycobacterial ATP
synthase, including inhibition studies using two different antibiotics,
TMC207 and meﬂoquine. TMC207 inhibited 50% of ATP synthesis at
0.03 μM. In contrast, meﬂoquine was less active, but nevertheless still
an efﬁcient inhibitor of the mycobacterial ATP synthase at 15 μM
(IC50). We then puriﬁed a mycobacterial ATP synthase rotor (c-) ring
and established a drug competition assay using the well known ATP
synthesis inhibitor dicyclohexylcarbodiimide (DCCD). The results
show that TMC207 competes with DCCD at the proton binding site of
the c-ring. This is direct biochemical proof that the c-ring's ion
binding site is the actual target of the drug, to which it binds with
high afﬁnity and speciﬁcity. Similar results were found for meﬂoquine,
although we detected lower afﬁnities for the proton binding site. To
further explore the highly speciﬁc drug-target interaction of TMC207
with the mycobacterial c-ring, we aim to solve its structure in complex
with TMC207. X-ray diffracting 3D crystals of the rotor ring-drug complex
are available. This work provides insights into the speciﬁc interaction of
the isolated mycobacterial ATP synthase rotor ring with a novel and
highly potent drug, in the perspective to treat infections in patients with
MDRM. tuberculosis strains. Based on these results, an optimisation of
TMC207 derivatives and further development of drugs, which target
the ATP synthase to treat TB becomes conceivable.
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H+-FOF1-ATP-synthase catalyzes generation of ATP from ADP and
inorganic phosphate using the energy of transmembrane electro-
chemical potential difference of protons. This enzyme can function in
opposite direction as ATP-driven proton pump. ADP-inhibition is
known to reduce this ATPase activity: ADP without phosphate binds
empty catalytic site and this binding induces transition of enzyme to
ADP-inhibited state.
We studied ADP-inhibition on inverted membranes from Escherichia
coli. ATP hydrolysis is accompanied by stoichiometric proton release
at pHN7.2. This acidiﬁcation was measured by pH indicator phenol
red absorption changes.
We studied wild-type enzyme at room temperature (24 °C ) and
37 °C. At room temperature ADP-inhibition was weaker than at 37 °C.
Also we studied the inﬂuence of inorganic phosphate on the ADP-
inhibition of the enzyme. In the presence of phosphate ADP-
inhibition increased in the wild-type enzyme.
It was shown previously [1] that mutation Met23Lys in the γ
subunit of the enzyme enhanced ADP-inhibition compared to the
wild-type enzyme in purple bacteria Rhodobacter capsulatus. Our
results indicate that mutation showed the same effect on membranes
from E.coli at 37 °C, but at room temperature this effect was reversed
as in the wild type. Inorganic phosphate enhanced ADP-inhibition of
the enzyme carrying this mutation.
We also found that enzyme with mutation βLeu249Gln situated
on the interface between α and β subunits had weak ADP-inhibition
at 24 °C, but at 37 °C the inhibition was stronger. In contrast to
γMet23Lys and wild-type, addition of phosphate reduced ADP-
inhibition of the βL249Q mutant. Our results allow us to suppose
that this position is important for modulation of ADP-inhibition by
phosphate.
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The mitochondrial F1F0-ATP synthase is one of the most ubiqui-
tously studied enzymes. In physiological conditions it carries out ATP
synthesis, utilizing the H+ gradient generated by the Electron
Respiratory Chain. When mitochondrial function is compromised,
the enzyme acts as ATP consumer depleting cells from ATP which is
inhibited by IF1-the natural endogenous inhibitor of ATP synthase [1].
Recent reports, including ours [2], have suggested the presence of
subunits or thewhole complex on the cell surface of various cell types [3].
Both by immunoﬂuorescent and western blotting analyses, we
found that IF1 co-localizes with the ATP synthase (β-subunit) and
ﬂotillin, a lipid raft marker, on the cell surface of HeLa cells. The OSCP,
a subunit of the ATP synthase assembled at very late stage, was also
found to pair the β-subunit and IF1 in non-permeabilized cells,
suggesting the presence of a small functional mitochondria-like
organization. Notably, cholesterol loading, performed at different
time intervals, reduced the mitochondrial content of IF1, with a
parallel increase of the ectopic expression.
In conclusion, our data report that IF1 (re)localizes in the lipid rafts
of plasma membranes in association with the F1F0-ATPase depending
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